scholarly article | Q13442814 |
P50 | author | Muredach P. Reilly | Q51505621 |
Daniel Rader | Q56255391 | ||
P2093 | author name string | Robert C Bauer | |
Ioannis M Stylianou | |||
P2860 | cites work | Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 |
Genome-wide association studies for complex traits: consensus, uncertainty and challenges | Q24550632 | ||
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice | Q24563208 | ||
Biological, clinical and population relevance of 95 loci for blood lipids | Q24622541 | ||
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice | Q24623151 | ||
Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow | Q80058470 | ||
Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse | Q80576647 | ||
Loss of lysophospholipase 3 increases atherosclerosis in apolipoprotein E-deficient mice | Q81552542 | ||
Quantitative trait locus analysis for obesity reveals multiple networks of interacting loci | Q82276606 | ||
Lack of support for association between common variation in TNFSF4 and myocardial infarction in a German population | Q82707761 | ||
Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells | Q83305041 | ||
Histamine deficiency decreases atherosclerosis and inflammatory response in apolipoprotein E knockout mice independently of serum cholesterol level | Q83313792 | ||
Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population | Q83543008 | ||
Unexpected protective role for Toll-like receptor 3 in the arterial wall | Q24624935 | ||
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk | Q24630394 | ||
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants | Q24645076 | ||
A common allele on chromosome 9 associated with coronary heart disease | Q24647989 | ||
Genomewide association analysis of coronary artery disease | Q24658344 | ||
Mutation of MEF2A in an inherited disorder with features of coronary artery disease | Q24669679 | ||
Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice | Q24680458 | ||
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice | Q24681021 | ||
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis | Q28198287 | ||
Reflections on glycobiology | Q28216036 | ||
ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques | Q28235056 | ||
Proteoglycans in atherosclerosis and restenosis: key roles for versican | Q28261672 | ||
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction | Q28308221 | ||
Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E | Q28344980 | ||
Increased atherosclerosis in myeloperoxidase-deficient mice | Q28350068 | ||
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice | Q28364478 | ||
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis | Q28365883 | ||
Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice | Q28505210 | ||
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
Murine equivalent of the human histo-blood group ABO gene is a cis-AB gene and encodes a glycosyltransferase with both A and B transferase activity | Q28511961 | ||
Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms | Q28579031 | ||
A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice | Q28589301 | ||
A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo | Q28592009 | ||
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis | Q28592044 | ||
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm | Q28943557 | ||
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies | Q29417010 | ||
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease | Q29417023 | ||
A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease | Q29417111 | ||
The ADAMTS metalloproteinases | Q29544428 | ||
Missing heritability and strategies for finding the underlying causes of complex disease | Q29614586 | ||
A common variant on chromosome 9p21 affects the risk of myocardial infarction | Q29614954 | ||
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery | Q29615235 | ||
Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 | Q29616092 | ||
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease | Q29616310 | ||
Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
Systemic Deficiency of the MAP Kinase–Activated Protein Kinase 2 Reduces Atherosclerosis in Hypercholesterolemic Mice | Q57243652 | ||
Relationship Between Coronary Artery Calcification and Other Measures of Subclinical Cardiovascular Disease in Older Adults | Q57392457 | ||
Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans | Q57607729 | ||
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection | Q59068486 | ||
Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice | Q59284858 | ||
Fine mapping of Ath6, a quantitative trait locus for atherosclerosis in mice | Q59797751 | ||
ABO blood group and cardiovacular disease: the Framingham study | Q68229326 | ||
Genetic susceptibility to death from coronary heart disease in a study of twins | Q72290929 | ||
Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice | Q73343248 | ||
Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia | Q73703942 | ||
Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects | Q74397732 | ||
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha | Q77677370 | ||
Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J | Q77959289 | ||
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice | Q79903873 | ||
P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice | Q36375890 | ||
CD1d-dependent activation of NKT cells aggravates atherosclerosis. | Q36399122 | ||
Applying gene expression, proteomics and single-nucleotide polymorphism analysis for complex trait gene identification | Q36515674 | ||
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice | Q36524275 | ||
Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model | Q36531841 | ||
Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis | Q36586261 | ||
Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis | Q36660105 | ||
Influence of PDZK1 on lipoprotein metabolism and atherosclerosis | Q36708971 | ||
Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study | Q36787671 | ||
Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis | Q36806897 | ||
The problem of passenger genes in transgenic mice | Q36906551 | ||
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E | Q36986664 | ||
Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding | Q37141472 | ||
Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. | Q37169153 | ||
Arterial remodeling in vascular disease: a key role for hyaluronan and versican | Q37175421 | ||
New susceptibility locus for coronary artery disease on chromosome 3q22.3. | Q37225243 | ||
Four additional mouse crosses improve the lipid QTL landscape and identify Lipg as a QTL gene | Q37337457 | ||
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
Farp2 and Stk25 are candidate genes for the HDL cholesterol locus on mouse chromosome 1. | Q37435699 | ||
Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice | Q37461235 | ||
Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10. | Q37467868 | ||
11β-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice | Q37687153 | ||
The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein | Q37794678 | ||
Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. | Q38299150 | ||
9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response | Q39048288 | ||
Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2. | Q39347729 | ||
Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. | Q39673704 | ||
Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. | Q39961306 | ||
A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development | Q40391470 | ||
Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. | Q40493102 | ||
Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation | Q40608307 | ||
Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. | Q40716232 | ||
Apolipoprotein E and the apolipoprotein E-deficient mouse | Q40926150 | ||
Candidate genes, small effects, and the prediction of atherosclerosis | Q41588632 | ||
MEF2A sequence variants and coronary artery disease: a change of heart? | Q42710739 | ||
Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion | Q43212308 | ||
Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis. | Q43282401 | ||
Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia | Q43415395 | ||
Reduced atherosclerotic lesion size in P-selectin deficient apolipoprotein E-knockout mice fed a chow but not a fat diet | Q34897655 | ||
ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries | Q34929435 | ||
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice | Q34967612 | ||
Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. | Q34991776 | ||
Complex genetic architecture revealed by analysis of high-density lipoprotein cholesterol in chromosome substitution strains and F2 crosses | Q35083041 | ||
Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. | Q35088170 | ||
Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice | Q35144122 | ||
Genetic analysis in the Collaborative Cross breeding population. | Q35145484 | ||
Collaborative Cross mice and their power to map host susceptibility to Aspergillus fumigatus infection | Q35145488 | ||
Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses | Q35173629 | ||
Controversy in human genetics. ABO blood groups and disease | Q35232224 | ||
ABO blood type and arteriosclerosis obliterans | Q35569071 | ||
Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology | Q35603368 | ||
Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences | Q35606510 | ||
Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches | Q35708128 | ||
Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis | Q35781497 | ||
Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. | Q35791953 | ||
Strategies for mapping and cloning quantitative trait genes in rodents | Q36085684 | ||
Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis | Q36095672 | ||
Genetic and genomic insights into the molecular basis of atherosclerosis | Q36155114 | ||
Bioinformatics toolbox for narrowing rodent quantitative trait loci | Q36286902 | ||
Diet and murine atherosclerosis | Q36350935 | ||
Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice | Q36357458 | ||
Quantitative trait locus analysis of atherosclerosis in an intercross between C57BL/6 and C3H mice carrying the mutant apolipoprotein E gene | Q30439110 | ||
Quantitative trait locus analysis of carotid atherosclerosis in an intercross between C57BL/6 and C3H apolipoprotein E-deficient mice | Q30443593 | ||
Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data | Q31119283 | ||
Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice | Q33331307 | ||
Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies | Q33381588 | ||
Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice | Q33386022 | ||
Genetic markers in atherosclerosis: a review | Q33586849 | ||
Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4. | Q33637168 | ||
ADAMTS proteases: key roles in atherosclerosis? | Q33638605 | ||
Differences in DBA/1J and DBA/2J reveal lipid QTL genes | Q33712893 | ||
Aortic arch curvature and atherosclerosis have overlapping quantitative trait loci in a cross between 129S6/SvEvTac and C57BL/6J apolipoprotein E-null mice | Q33767143 | ||
T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses | Q33819043 | ||
Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. | Q33908525 | ||
Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment | Q33938891 | ||
Ath-2, a second gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice | Q33955303 | ||
Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E | Q33962949 | ||
Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice | Q34002830 | ||
Identifying novel genes for atherosclerosis through mouse-human comparative genetics | Q34021005 | ||
Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries | Q34098485 | ||
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice | Q34121996 | ||
LRP6 mutation in a family with early coronary disease and metabolic risk factors | Q34153785 | ||
LRP: role in vascular wall integrity and protection from atherosclerosis | Q34190034 | ||
Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice | Q34248316 | ||
Finding the molecular basis of quantitative traits: successes and pitfalls. | Q34271555 | ||
Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice | Q34330253 | ||
Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice | Q34455303 | ||
ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein | Q34508676 | ||
A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse | Q34614796 | ||
Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. | Q34619960 | ||
Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis | Q34652627 | ||
The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels | Q34793225 | ||
Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis | Q34828549 | ||
Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice | Q34895911 | ||
Synthetic low and high fat diets for the study of atherosclerosis in the mouse | Q43607933 | ||
Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. | Q43653260 | ||
Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice. | Q43693015 | ||
Localized reduction of atherosclerosis in von Willebrand factor-deficient mice | Q43718531 | ||
Ultrafine mapping of SNPs from mouse strains C57BL/6J, DBA/2J, and C57BLKS/J for loci contributing to diabetes and atherosclerosis susceptibility | Q43798122 | ||
Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages | Q43957626 | ||
Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice | Q44079670 | ||
Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice | Q44201386 | ||
Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse | Q44342113 | ||
Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion | Q44357150 | ||
Tissue angiotensin-converting-enzyme (ACE) deficiency leads to a reduction in oxidative stress and in atherosclerosis: studies in ACE-knockout mice type 2. | Q44606455 | ||
Genetic ablation of caveolin-1 confers protection against atherosclerosis | Q44620779 | ||
Quantitative Trait Loci Analysis for Plasma HDL-Cholesterol Concentrations and Atherosclerosis Susceptibility Between Inbred Mouse Strains C57BL/6J and 129S1/SvImJ | Q44639031 | ||
Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis | Q44771606 | ||
ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. | Q44836516 | ||
Genetic loci for diet-induced atherosclerotic lesions and plasma lipids in mice | Q45000599 | ||
Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice | Q45013809 | ||
Alpha(1,3)fucosyltransferases FucT-IV and FucT-VII control susceptibility to atherosclerosis in apolipoprotein E-/- mice | Q45016522 | ||
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. | Q45025551 | ||
Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. | Q45158735 | ||
Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis | Q45165256 | ||
Regulation of cholesterol 7alpha-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet. | Q45253376 | ||
Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility | Q45306054 | ||
Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet | Q45867832 | ||
Genetic analysis of strains C57BL/6J and BALB/cJ for Ath-1, a gene determining atherosclerosis susceptibility in mice. | Q46003130 | ||
ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. | Q46014277 | ||
Analysis of atherosclerosis susceptibility in mice with genetic defects in platelet function | Q46122913 | ||
Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis | Q46191272 | ||
Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice | Q46492183 | ||
Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. | Q46624696 | ||
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice | Q46722608 | ||
A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. | Q46778536 | ||
Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy | Q46823870 | ||
Atherosclerosis susceptibility loci identified from a strain intercross of apolipoprotein E-deficient mice via a high-density genome scan. | Q46864803 | ||
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice | Q47392093 | ||
Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. | Q51562630 | ||
Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. | Q53460669 | ||
Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice. | Q53588364 | ||
The p16INK4a/CDKN2A tumor suppressor and its relatives. | Q54317457 | ||
ATH-3, a new gene for atherosclerosis in the mouse. | Q54356341 | ||
Apoptosis signal-regulating kinase 1 deficiency accelerates hyperlipidemia-induced atheromatous plaques via suppression of macrophage apoptosis. | Q54593658 | ||
Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. | Q54689510 | ||
The Collaborative Cross, a community resource for the genetic analysis of complex traits | Q56896214 | ||
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke | Q56944340 | ||
P433 | issue | 2 | |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 337-355 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Circulation Research | Q2599020 |
P1476 | title | Genetic basis of atherosclerosis: insights from mice and humans | |
P478 | volume | 110 |
Q43751225 | A coding variant in SR-BI (I179N) significantly increases atherosclerosis in mice |
Q35847610 | A comparison of human and mouse gene co-expression networks reveals conservation and divergence at the tissue, pathway and disease levels |
Q36843340 | ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis |
Q39028912 | Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis |
Q35085174 | Association of the RYR3 gene polymorphisms with atherosclerosis in elderly Japanese population |
Q36004778 | Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome |
Q30416293 | Atherosclerosis susceptibility Loci identified in an extremely atherosclerosis-resistant mouse strain |
Q38000082 | Atherosclerosis, inflammation, genetics, and stem cells: 2012 update |
Q42176949 | Clinical relevance of gemstone spectral CT in the diagnosis of carotid atherosclerosis |
Q39294873 | Construction and phenotypic analysis of mice carrying a duplication of the major histocompatibility class I (MHC-I) locus. |
Q36584577 | Differences in health status affect susceptibility and mapping of genetic loci for atherosclerosis (fatty streak) in inbred mice |
Q38888696 | Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis? |
Q43482569 | FOXP3 genetic variant and risk of acute coronary syndrome in Chinese Han population |
Q34429737 | Functional characterization of newly-discovered mutations in human SR-BI |
Q37667665 | Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks |
Q33927042 | Gene expression analyses of mouse aortic endothelium in response to atherogenic stimuli |
Q31122524 | Gene expression differences during the heterogeneous progression of peripheral atherosclerosis in familial hypercholesterolemic swine |
Q27309881 | Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains |
Q39450537 | Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice |
Q34553141 | Genetics of coronary artery disease: discovery, biology and clinical translation |
Q34344282 | Identification of CAD candidate genes in GWAS loci and their expression in vascular cells |
Q90524396 | In Search for Genes Related to Atherosclerosis and Dyslipidemia Using Animal Models |
Q37730893 | Nutrigenetics and nutrigenomics of atherosclerosis |
Q26800058 | PET Imaging of the Human Nicotinic Cholinergic Pathway in Atherosclerosis |
Q26829774 | Recent developments in cardiovascular genetics and genomics |
Q38634721 | Role of neutrophils in atherogenesis: an update |
Q34300349 | SR-BI/CD36 chimeric receptors define extracellular subdomains of SR-BI critical for cholesterol transport |
Q35095828 | Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease |
Q36960706 | Systematic analysis of the molecular mechanism underlying atherosclerosis using a text mining approach |
Q41039109 | TRIB1 is a positive regulator of hepatocyte nuclear factor 4-alpha |
Q35604441 | The DNA methylation drift of the atherosclerotic aorta increases with lesion progression |
Search more.